<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02033798</url>
  </required_header>
  <id_info>
    <org_study_id>L201401N2</org_study_id>
    <nct_id>NCT02033798</nct_id>
  </id_info>
  <brief_title>The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia</brief_title>
  <official_title>Impact of Medical Treatment for Benign Prostatic Hyperplasia on Chronic Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether medical treatment for bladder outlet
      obstruction is effective in improvement of glomerular filtration rate and/or proteinuria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Urodynamic parameters including maximal flow rate, compliance (infused volume gradient
      divided by bladder pressure gradient during cystometry), maximal detrusor pressure, bladder
      outlet obstruction index and Sch채fer grade will be checked.

      Estimated glomerular filtration rate and urinary protein to creatinine ratio will be checked.

      International prostate symptom score will be checked.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal flow rate</measure>
    <time_frame>6 months</time_frame>
    <description>This parameter can be obtained from urodynamic study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal detrusor pressure</measure>
    <time_frame>6 months</time_frame>
    <description>This parameter can be obtained from urodynamic study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bladder outlet obstruction index</measure>
    <time_frame>6 months</time_frame>
    <description>This parameter can be obtained from urodynamic study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sch채fer grade</measure>
    <time_frame>6 months</time_frame>
    <description>This parameter can be obtained from urodynamic study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compliance</measure>
    <time_frame>6 months</time_frame>
    <description>This parameter can be obtained from urodynamic study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimated glomerular filtration rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary protein to creatinine ratio</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>International prostate symptom score</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Chronic Kidney Failure</condition>
  <condition>Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>Tamsulosin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The dosage form of Tamsulosin is tablet, dosage is 0.2mg, frequency is once daily and duration is 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <description>Once Daily 0.2mg per oral for 6 months</description>
    <arm_group_label>Tamsulosin</arm_group_label>
    <other_name>Harnal D</other_name>
    <other_name>Tamsnal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men with low urinary tract symptoms aged between 40 and 80

          -  Estimated glomerular filtration rate &lt; 60 or evidence of proteinuria

          -  Bladder outlet obstruction index &gt; 40, Sch채fer grade 2 or more, maximal flow rate
             lower than 10 cc/s or postvoid residual urine &gt; 100cc

        Exclusion Criteria:

          -  Bladder outlet obstruction index less than 40, Sch채fer grade 0 or 1, maximal flow rate
             higher than 10 ml/s and postvoid residual urine less than 100cc

          -  Want surgical procedure

          -  Evidence of prostate cancer or bladder cancer

          -  Major depressive disorder, Dementia, Parkinson's disease or neurological deficits

          -  History of pelvic irradiation

          -  Uncontrolled diabetes mellitus or hypertension

          -  Symptomatic orthostatic hypotension
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-Ju Lee, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Sup Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung-Ju Lee, MD, PhD</last_name>
    <phone>82-31-249-8305</phone>
    <email>lee.seungju@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dong Sup Lee, MD, PhD</last_name>
    <phone>82-31-249-8276</phone>
    <email>lds@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>442-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seung-Ju Lee Lee, MD, PhD</last_name>
      <phone>82-31-249-8305</phone>
      <email>lee.seungju@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2014</study_first_posted>
  <last_update_submitted>January 15, 2014</last_update_submitted>
  <last_update_submitted_qc>January 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Seung-Ju Lee</investigator_full_name>
    <investigator_title>Senior researcher</investigator_title>
  </responsible_party>
  <keyword>Urodynamics</keyword>
  <keyword>Glomerular Filtration Rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

